Acrobiosystems Co.,Ltd. (SHE:301080)

China · Delayed Price · Currency is CNY

45.00

+1.61 (3.71%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Research and Experimental Development	632.94M	532.80M	466.58M	376.71M	239.78M
Research and Experimental Development Growth	18.79%	14.19%	23.86%	57.11%	132.14%
Unallocated Others	12.09M	10.85M	7.85M	8.28M	6.54M
Unallocated Others Growth	11.35%	38.24%	-5.12%	26.62%	-
Total	645.02M	543.65M	474.43M	384.99M	246.32M
Total Growth	18.65%	14.59%	23.23%	56.30%	138.47%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China	216.36M	185.30M	179.85M	160.56M	79.31M
China Growth	16.76%	3.03%	12.01%	102.46%	111.31%
Overseas	428.67M	358.35M	294.58M	224.43M	167.01M
Overseas Growth	19.62%	21.65%	31.26%	34.38%	163.13%
Total	645.02M	543.65M	474.43M	384.99M	246.32M
Total Growth	18.65%	14.59%	23.23%	56.30%	143.87%

Source: S&P Global Market Intelligence.